ProgrammableMarketing/xenon-pharma.com (opens in a new tab)
PDF

Views

  • Plan
  • Roadmap
  • Research

On this page

  • The brief
  • Start here
  • Idea portfolio
  • Effort vs impact
  • This week · 6
  • This quarter · 9
  • Big bets · 3
  • Wildcards · 2
  • How we can help
Generated Oct 26, 2026 1 view
  1. Programmable
  2. Playbooks
  3. Xenon Pharmaceuticals
Xenon Pharmaceuticals logo

growth playbook · Oct 26, 2026

xenon-pharma.com (opens in a new tab)

Xenon Pharmaceuticals growth playbook

Diagnosis

Xenon is turning from a research company into a commercial one: its job board shows new Corporate Communications, Patient Marketing, Medical Information, MSL, Strategic Engagement and payer roles.

Its corporate site is clear and passes Core Web Vitals for real visitors, but its news reaches the page only after scripts run, the About timeline stops before the NDA submission, the sitemap lists 7 pages, there is no Medical Information page, and the publications library sits on the investor site.

This playbook fixes those first, then builds compliant routes for HCPs, payers and investigators, partner-led unbranded education, and a shared content and measurement system for the new teams. Nothing here promotes an investigational medicine; every asset goes through medical, legal and regulatory review.

Growth Score

7/10

Biggest Opportunity

Make xenon-pharma.com the trusted front door for the specialists, partners and payers the new teams are about to meet: current news, a full publications library, a Medical Information route and fast MSL follow-up.

Biggest Risk

Pre-approval communication rules leave little room for error, and the company's own pages must stay in step with its announcements on regulatory and trial status while new teams publish more.

01

Start here

The three moves to make first. Each one is written up in full below.

  1. 1

    Put the NDA milestone and recent news into the pages people and crawlers actually read

    Add the NDA submission to the About page timeline.

    High impact First result in 2 weeks
  2. 2

    Show each study's current enrollment status on the clinical trials page

    Agree status wording for each study with Clinical Operations and Regulatory.

    High impact First result in 1 week
  3. 3

    Proofread the scientific pages: typos and broken paper titles

    Fix "placeo" and "breakthoughs" today.

    Medium impact First result in 1 week

02

Your idea portfolio

20 ideas, grouped by when to run them. Open any idea for how to run it: the steps, who to approach, copy you can use, and how to measure it.

  • 7 ideas are marked Unexpected: plays you are unlikely to have tried.

Every idea placed by the effort it takes against the impact it could have. Quick wins sit top left; select a number to open that idea. The filters below narrow the list by status, timing, category and what Programmable can build.

Effort vs impactEach number is an idea. Select one to open it.
Impact →
Quick wins · 5Big bets · 7Fill-ins · 6Reconsider · 2
Effort →

Showing 20 of 20 ideas

This week 6

Quick wins with a clear first action.

  • 01

    The new Corporate Communications lead is hired to "increase awareness and visibility of Xenon's emerging leadership in epilepsy" and to own corporate newsflow. But on xenon-pharma.com the "Recent news" sections on the homepage and Media page arrive only after the browser runs scripts: the HTML the server sends shows a loading spinner. The About page timeline stops at the March X-TOLE2 topline results, with no entry for the NDA submission the company announced in September, and the sitemap lists 7 pages while leaving out the Healthcare providers, Media and Therapeutic areas pages.

    High impactLow effort First result in 2 weeks Director/Senior Director

    First action

    Add the NDA submission to the About page timeline.

    How to measure it

    Pages listed in the sitemap

    Now
    –
    Target
    All public pages
    By
    30 days

    Steps

    1. 1

      Agree the wording

      Timeline entry from the September release.

      Director/Senior Director, Corporate Communications 1 day

    2. 2

      Review

      Approve the entry and news block.

      Medical, Legal and Regulatory review 2 days

    3. 3

      Server-render news

      Latest five releases in the HTML.

      Digital and web team 3 days

    4. 4

      Rebuild the sitemap

      From routes, with real dates.

      Digital and web team 1 day

    5. 5

      Share images

      Default image and full descriptions.

      Digital and web team 1 day

    6. 6

      Check previews

      LinkedIn, X and email previews of key pages.

      Director/Senior Director, Corporate Communications 1 hour

    7. 7

      Keep current

      Add each milestone the day it is announced.

      Director/Senior Director, Corporate Communications ongoing

    First result
    2 weeks
    Cost
    A few days of web development
    Owner
    Director/Senior Director, Corporate Communications

    Smallest test

    Render the news list on the Media page first and check its link preview.

    Why it works

    Render the latest five press releases into the homepage and Media page HTML on the server (title, date, link to the investor site), add the September NDA submission to the About timeline in the company's own approved wording, and generate the sitemap from the site's routes so every public page is listed with its real update date. Add a default share image and complete the cut-off share descriptions at the same time.

    Journalists, analysts, prospective hires and HCPs often meet Xenon through a link preview, a search result or an AI assistant's summary. Each of those reads the server HTML and the sitemap, so the company's biggest milestone should be in both.

    Ready to use

    ChecklistNewsflow on the corporate site

    [ ] Latest press releases in server HTML on / and /media
    [ ] NDA submission on the About timeline (approved wording)
    [ ] Sitemap includes /health-care-providers, /media, /pipeline/therapeutic-areas, /contact-us
    [ ] Real lastmod dates per page
    [ ] Default og:image and full og:description on every page
    [ ] Open positions rendered in server HTML on /join-us
    [ ] Milestone checklist added to the release-day runbook

    Risks and how to handle them

    • Wording about regulatory status

      Reuse only the approved press release language.

    • Two sites drift apart

      Pull news from the investor site feed rather than copying by hand.

    Evidence

    • HiringDirector/Senior Director, Corporate Communications (Needham, MA, posted September 8, 2026): "Increase awareness and visibility of Xenon's emerging leadership in epilepsy, including forthcoming potential launch of azetukalner in focal seizures and our emergence as a leading biopharma company soon to be a fully integrated commercial organization"; owns "corporate newsflow, including business updates, clinical trial milestones, data readouts and future product launches" for "investors and media, healthcare professionals, and the patient community".Source
    • Your websiteHomepage and Media page (checked twice on October 23, 2026): the "Recent news" section is filled in by the browser; the HTML the server sends shows only a loading spinner, so link previews, many crawlers and AI assistants see no news on xenon-pharma.com. The Join Us page's open positions likewise say "Loading open positions...". Press releases live on investor.xenon-pharma.com.Source
    • Your websiteAbout page milestone timeline: the newest entry is "Announced positive topline results from Phase 3 X-TOLE2 study of azetukalner in focal onset seizures"; the September NDA submission is not listed.Source
    • Your websiteSitemap (checked October 23, 2026): 7 URLs, all with the same lastmod; it omits linked pages such as /health-care-providers, /media, /pipeline/therapeutic-areas and /contact-us. The homepage has no social share image, and the Patients page's share description is cut off at "Patient collaboration drives the".Source
    • HiringCompany description in every job post: "In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we submitted a New Drug Application to the Food and Drug Administration in the third quarter of 2026"; X-TOLE3 "would support regulatory submissions outside the U.S."; X-ACKT is in primary generalized tonic-clonic seizures. The Ashby board lists 25 open roles across Boston, Vancouver and U.S. field territories, including CMC and quality roles for "Late Stage/Commercial" manufacturing.Source
  • 02

    Xenon's September 17 release announced a temporary pause of enrollment of new patients in ongoing psychiatry studies, but the clinical trials page still introduces the depression studies with "To learn more about enrollment in the study, visit" and registry links, with no status beside them.

    High impactLow effort First result in 1 week Director

    First action

    Agree status wording for each study with Clinical Operations and Regulatory.

    How to measure it

    Studies with a current status label

    Now
    –
    Target
    All
    By
    2 weeks

    Steps

    1. 1

      List studies

      Every study on the page.

      Director, Medical Information 1 day

    2. 2

      Confirm status

      With Clinical Operations.

      Director, Medical Information 1 day

    3. 3

      Approve wording

      Status labels.

      Medical, Legal and Regulatory review 2 days

    4. 4

      Add labels

      With last-checked date.

      Digital and web team 1 day

    5. 5

      Add to runbook

      Update on each change.

      Director/Senior Director, Corporate Communications 1 day

    6. 6

      Review monthly

      Against registry entries.

      Director, Medical Information monthly

    First result
    1 week
    Cost
    Staff time only
    Owner
    Director, Medical Information

    Smallest test

    Add status labels to the four psychiatry links first.

    Why it works

    Add a status label to each study (for example "Enrolling", "Enrollment complete", "New enrollment paused") in the approved wording, with the date it was last checked and a link to the registry entry. Make updating it part of the release-day checklist.

    People who reach the page, including referring physicians and investigators, get accurate expectations, and the page stays consistent with the company's own announcements.

    Risks and how to handle them

    • Status changes again

      Show a last-checked date and update on each release.

    Evidence

    • Your websiteClinical trials page: study designs for focal seizures (X-TOLE2, X-TOLE3), generalized seizures (X-ACKT), major depressive disorder (X-NOVA2, X-NOVA3) and bipolar depression (X-CEED), each followed by "To learn more about enrollment in the study, visit:" and ClinicalTrials.gov links; investigator inquiries go to study email addresses; general questions to [email protected]; the page contains the typo "placeo".Source
    • Company announcementXenon's September 17, 2026 release: it submitted an NDA for azetukalner in focal seizures and "voluntarily initiated a temporary pause of enrollment of new patients in ongoing psychiatry studies"; patients already enrolled continue.Source
    • HiringDirector, Medical Information (posted August 13, 2026): build the Medical Information function, including "contact center operations, digital capabilities, and scientific content management", "Standard Response Letters (SRLs)", "omnichannel MI delivery and self-service portals" and "a Medical Information portal".Source
  • 03

    The clinical trials page says "placeo", the Patients page says "Driven by scientific breakthoughs", and on the Healthcare providers page screen readers hear raw markup ("K<sub>V</sub>7") in two publication titles. These are pages read by neurologists, investigators and patient advocates.

    Medium impactLow effort First result in 1 week Medical

    First action

    Fix "placeo" and "breakthoughs" today.

    How to measure it

    Typos and markup errors

    Now
    –
    Target
    0
    By
    2 weeks

    Steps

    1. 1

      Proofread

      Every page.

      Medical, Legal and Regulatory review 1 day

    2. 2

      Fix typos

      In the content system.

      Digital and web team 1 hour

    3. 3

      Fix titles

      Strip markup from screen-reader text.

      Digital and web team 2 hours

    4. 4

      Accessibility check

      Automated and manual.

      Digital and web team 1 day

    5. 5

      Add checks

      Spell check before publishing.

      Digital and web team 1 day

    6. 6

      Review quarterly

      Repeat the proofread.

      Medical, Legal and Regulatory review quarterly

    First result
    1 week
    Cost
    $0
    Owner
    Medical, Legal and Regulatory review

    Smallest test

    Fix the two typos this week.

    Why it works

    Run a full proofread and accessibility check of every page, fix the typos and the markup in titles in the content system, and add a spell check and a screen-reader preview to the publishing workflow.

    Small errors on scientific pages read as carelessness to the expert audiences the field teams are building relationships with.

    Risks and how to handle them

    • Edits to approved copy

      Route fixes through the usual review.

    Evidence

    • Your websiteClinical trials page: study designs for focal seizures (X-TOLE2, X-TOLE3), generalized seizures (X-ACKT), major depressive disorder (X-NOVA2, X-NOVA3) and bipolar depression (X-CEED), each followed by "To learn more about enrollment in the study, visit:" and ClinicalTrials.gov links; investigator inquiries go to study email addresses; general questions to [email protected]; the page contains the typo "placeo".Source
    • Your websitePatients page: nine community partners (including Epilepsy Foundation of America, Child Neurology Foundation, Cure Epilepsy, Danny Did Foundation and International Bureau for Epilepsy), links to partner resources, an "Ask the Epileptologist" video series, employee stories, and the heading "Driven by scientific breakthoughs".Source
    • Your websiteHealthcare providers page: a "Meet With Your MSL" form (name, NPI number, title, institution, city, state or province); four featured publications (Epilepsia Open, JAMA Network Open, JAMA Neurology); "View All Publications" leaves for investor.xenon-pharma.com/publications; the screen-reader titles of two papers contain raw markup such as "K<sub>V</sub>7".Source
  • 04

    The Healthcare providers page shows four papers and sends "View All Publications" to the investor site. MSLs are hired to answer unsolicited requests and support HCP education, and a neurologist following a link expects the science to sit with the provider information.

    High impactLow effort First result in 1 month Senior Medical Science Liaison

    First action

    List every publication and congress presentation from the investor page.

    How to measure it

    MSL requests from the library

    Now
    –
    Target
    +25%
    By
    1 quarter

    Steps

    1. 1

      Inventory

      Papers and posters.

      Senior Medical Science Liaison 1 week

    2. 2

      Approve list

      What can be posted.

      Medical, Legal and Regulatory review 1 week

    3. 3

      Build the library

      Filters and citations.

      Digital and web team 1 week

    4. 4

      Link MSL form

      On each item.

      Digital and web team 1 day

    5. 5

      Update

      After each congress.

      Senior Medical Science Liaison per congress

    6. 6

      Measure

      Visits and MSL requests.

      Digital and web team monthly

    First result
    1 month
    Cost
    Web development time
    Owner
    Senior Medical Science Liaison

    Smallest test

    Move the full list onto the page as a simple table first.

    Why it works

    Build a publications and presentations library on the main site: filters by program and type (journal article, congress poster), plain citations, and links to the journal or the approved poster PDF, with a "Meet With Your MSL" link on each.

    One trusted place for the science shortens MSL follow-ups and keeps HCPs on the provider pages instead of the investor site.

    Risks and how to handle them

    • Posting rules for posters

      Post only items Medical Affairs approves for public posting.

    Evidence

    • Your websiteHealthcare providers page: a "Meet With Your MSL" form (name, NPI number, title, institution, city, state or province); four featured publications (Epilepsia Open, JAMA Network Open, JAMA Neurology); "View All Publications" leaves for investor.xenon-pharma.com/publications; the screen-reader titles of two papers contain raw markup such as "K<sub>V</sub>7".Source
    • HiringSenior Medical Science Liaison, Southeast (posted September 10, 2026): engages HCPs, KOLs and patient groups "to provide education on Xenon's pipeline in epilepsy"; responds to "unsolicited requests for scientific information"; supports "investigator identification for clinical programs in epilepsy"; leads congress activities.Source
    • HiringDirector, Strategic Engagements, Northeast and Central (both posted October 21, 2026): "KOL Engagement", "commercial KOL influence mapping", "field-based educational events (many occurring on weekends)", advisory boards and congresses, "in a compliant manner", reporting to the Senior Director, Customer Engagement.Source
  • 05

    Real Chrome visitors pass Core Web Vitals on the homepage, but Google's phone test downloads 15 MB and shows the main content after 10.9 s because the hero is a video. First-time visitors on mobile data, such as candidates and journalists clicking from LinkedIn, pay that cost.

    Medium impactLow effort First result in 2 weeks Digital and web team

    First action

    Export a poster frame from the hero video.

    How to measure it

    Lab LCP

    Now
    –
    Target
    under 3 s
    By
    30 days

    Steps

    1. 1

      Make a poster

      Compressed image.

      Digital and web team 1 hour

    2. 2

      Lazy-load video

      Fast connections only.

      Digital and web team 1 day

    3. 3

      Defer tags

      After first paint.

      Digital and web team 1 day

    4. 4

      Retest

      Lab and field.

      Digital and web team 1 week

    5. 5

      Check other pages

      Same pattern.

      Digital and web team 1 week

    6. 6

      Monitor

      Monthly field data.

      Digital and web team monthly

    First result
    2 weeks
    Cost
    $0
    Owner
    Digital and web team

    Smallest test

    Ship the poster image this week.

    Why it works

    Show a compressed poster image immediately, load the video only on fast connections and wider screens, and defer the tag manager. Recheck PageSpeed.

    A fast first view supports every audience the communications team is trying to reach and costs only a small change.

    Risks and how to handle them

    • Design team prefers motion

      Keep the video for desktop.

    Evidence

    • Google PageSpeedMobile lab test of the homepage: performance 55, Largest Contentful Paint 10.9 s (the hero video), 15 MB downloaded. Real Chrome visitors pass Core Web Vitals on the page (LCP 1.9 s, INP 134 ms), so the cost falls mainly on first visits on mobile data.Source
    • HiringDirector/Senior Director, Corporate Communications (Needham, MA, posted September 8, 2026): "Increase awareness and visibility of Xenon's emerging leadership in epilepsy, including forthcoming potential launch of azetukalner in focal seizures and our emergence as a leading biopharma company soon to be a fully integrated commercial organization"; owns "corporate newsflow, including business updates, clinical trial milestones, data readouts and future product launches" for "investors and media, healthcare professionals, and the patient community".Source
  • 06

    Xenon is building a Medical Information function with a contact center, standard response letters and a self-service portal. Today there is no Medical Information page; the contact form offers "Medical Affairs" but not Medical Information, and the medical information email appears only on two inner pages.

    High impactLow effort First result in 1 month Director

    First action

    Add Medical Information to the contact form's inquiry types.

    How to measure it

    MI requests through the site

    Now
    –
    Target
    Tracked weekly
    By
    1 quarter

    Steps

    1. 1

      Define scope

      Who and what the page covers.

      Director, Medical Information 1 week

    2. 2

      Write the page

      Routes and response times.

      Director, Medical Information 1 week

    3. 3

      Review

      Compliance and Legal.

      Medical, Legal and Regulatory review 1 week

    4. 4

      Build

      Page and form option.

      Digital and web team 3 days

    5. 5

      Route

      To the MI inbox and system.

      Director, Medical Information 2 days

    6. 6

      Report

      Requests and response times.

      Director, Medical Information monthly

    First result
    1 month
    Cost
    Staff time only
    Owner
    Director, Medical Information

    Smallest test

    Add the contact form option and a short page this month.

    Why it works

    Publish a /medical-information page: who it serves, how to submit a question (email, phone once the contact center is live, form), expected response times, and the link to request an MSL. Add a "Medical Information" option to the contact form and route it to the MI inbox.

    Unsolicited scientific questions are the compliant channel for HCPs before approval, and a clear front door makes them easy to ask and to track.

    Risks and how to handle them

    • Requests arrive before the contact center is ready

      Start with email and a stated response time.

    Evidence

    • HiringDirector, Medical Information (posted August 13, 2026): build the Medical Information function, including "contact center operations, digital capabilities, and scientific content management", "Standard Response Letters (SRLs)", "omnichannel MI delivery and self-service portals" and "a Medical Information portal".Source
    • Your websiteContact page: inquiry types are Business Development, Careers, Investors, Media and Medical Affairs; there is no Medical Information option or page, and the medical information email appears only on the clinical trials and healthcare providers pages. The Media page offers a media kit with logo, headshots and the epilepsy unmet-need infographic.Source
    • Your websiteHealthcare providers page: a "Meet With Your MSL" form (name, NPI number, title, institution, city, state or province); four featured publications (Epilepsia Open, JAMA Network Open, JAMA Neurology); "View All Publications" leaves for investor.xenon-pharma.com/publications; the screen-reader titles of two papers contain raw markup such as "K<sub>V</sub>7".Source
    • HiringSenior Medical Science Liaison, Southeast (posted September 10, 2026): engages HCPs, KOLs and patient groups "to provide education on Xenon's pipeline in epilepsy"; responds to "unsolicited requests for scientific information"; supports "investigator identification for clinical programs in epilepsy"; leads congress activities.Source

This quarter 9

The core plays for the next three months.

  • 07

    The MSL request form collects NPI, institution and state, and Xenon is hiring regional MSLs and Strategic Engagement directors for the Northeast, Central and Southeast. A form only helps if each request reaches the right person fast.

    High impactMedium effort First result in 1 quarter Director

    First action

    Check where today's form submissions go and how fast they are answered.

    How to measure it

    Median time to contact

    Now
    –
    Target
    2 business days
    By
    1 quarter

    Steps

    1. 1

      Map territories

      States to MSLs.

      Senior Medical Science Liaison 1 week

    2. 2

      Connect CRM

      Form to CRM record.

      Digital and web team 2 weeks

    3. 3

      Set targets

      First-contact time.

      Senior Medical Science Liaison 1 day

    4. 4

      Alert

      Overdue requests.

      Digital and web team 1 week

    5. 5

      Report

      By region monthly.

      Senior Medical Science Liaison monthly

    6. 6

      Share insights

      With Strategic Engagements.

      Director, Strategic Engagements monthly

    First result
    1 quarter
    Cost
    Integration time
    Owner
    Director, Strategic Engagements

    Smallest test

    Route one region's requests by hand for a month.

    Why it works

    Map states to MSL territories, send each request to the MSL and CRM with the NPI, set a two-business-day first-contact target, and report volume and time to contact by region to Medical Affairs.

    Prompt follow-up on an HCP's own request is the most valuable scientific exchange there is, and the data shows where demand is growing.

    Risks and how to handle them

    • Vacant territories

      Route to a backup MSL until filled.

    Evidence

    • Your websiteHealthcare providers page: a "Meet With Your MSL" form (name, NPI number, title, institution, city, state or province); four featured publications (Epilepsia Open, JAMA Network Open, JAMA Neurology); "View All Publications" leaves for investor.xenon-pharma.com/publications; the screen-reader titles of two papers contain raw markup such as "K<sub>V</sub>7".Source
    • HiringSenior Medical Science Liaison, Southeast (posted September 10, 2026): engages HCPs, KOLs and patient groups "to provide education on Xenon's pipeline in epilepsy"; responds to "unsolicited requests for scientific information"; supports "investigator identification for clinical programs in epilepsy"; leads congress activities.Source
    • HiringDirector, Strategic Engagements, Northeast and Central (both posted October 21, 2026): "KOL Engagement", "commercial KOL influence mapping", "field-based educational events (many occurring on weekends)", advisory boards and congresses, "in a compliant manner", reporting to the Senior Director, Customer Engagement.Source
  • 08

    Xenon already publishes "Ask the Epileptologist" conversations on uncontrolled seizures and treatment gaps, and its Strategic Engagement directors will run field-based educational events with epilepsy KOLs.

    High impactMedium effort First result in 1 quarter Director

    First action

    Plan four topics with Medical Affairs.

    How to measure it

    Series views

    Now
    –
    Target
    +50%
    By
    2 quarters

    Steps

    1. 1

      Pick topics

      Four disease-state themes.

      Director, Strategic Engagements 2 weeks

    2. 2

      Book specialists

      Two per episode.

      Director, Strategic Engagements 1 month

    3. 3

      Record

      Short conversations.

      Director/Senior Director, Corporate Communications quarterly

    4. 4

      Review

      Medical and Legal.

      Medical, Legal and Regulatory review 2 weeks

    5. 5

      Publish

      Provider pages and events.

      Digital and web team quarterly

    6. 6

      Measure

      Views and event use.

      Director, Strategic Engagements quarterly

    First result
    1 quarter
    Cost
    Production budget
    Owner
    Director, Strategic Engagements

    Smallest test

    Record one new episode.

    Why it works

    Plan a quarterly series of short, unbranded disease-state conversations (seizure burden, polytherapy, comorbidities) with the specialists Xenon works with, approved through medical review, published on the provider pages and cut for congress booths and educational events.

    Specialist-led education builds Xenon's standing in epilepsy with HCPs, and the content serves events, MSLs and the website at once.

    Risks and how to handle them

    • Drifting into product claims

      Keep the series unbranded and reviewed.

    Evidence

    • Your websitePatients page: nine community partners (including Epilepsy Foundation of America, Child Neurology Foundation, Cure Epilepsy, Danny Did Foundation and International Bureau for Epilepsy), links to partner resources, an "Ask the Epileptologist" video series, employee stories, and the heading "Driven by scientific breakthoughs".Source
    • Your websiteTherapeutic areas page: epilepsy "affects nearly 3 million adults in the U.S."; "more than 30 ASMs are available today. However, despite treatment, about half of people with focal epilepsy still live with uncontrolled seizures"; an unmet-need infographic and more "Ask the Epileptologist" conversations.Source
    • HiringDirector, Strategic Engagements, Northeast and Central (both posted October 21, 2026): "KOL Engagement", "commercial KOL influence mapping", "field-based educational events (many occurring on weekends)", advisory boards and congresses, "in a compliant manner", reporting to the Senior Director, Customer Engagement.Source
    • HiringDirector/Senior Director, Corporate Communications (Needham, MA, posted September 8, 2026): "Increase awareness and visibility of Xenon's emerging leadership in epilepsy, including forthcoming potential launch of azetukalner in focal seizures and our emergence as a leading biopharma company soon to be a fully integrated commercial organization"; owns "corporate newsflow, including business updates, clinical trial milestones, data readouts and future product launches" for "investors and media, healthcare professionals, and the patient community".Source
  • 09

    The National Account Director is hired to prepare national payers for Xenon's first launch and to communicate "the value proposition and HEOR data" appropriately. Payer staff look for a named contact and the published disease-burden research.

    High impactMedium effort First result in 2 quarters National Account Director

    First action

    Agree with Legal what the page may contain before approval.

    How to measure it

    Payer requests

    Now
    –
    Target
    Tracked monthly
    By
    2 quarters

    Steps

    1. 1

      Legal scope

      What can be shared and how.

      Medical, Legal and Regulatory review 1 month

    2. 2

      Write page

      Request route and publications.

      National Account Director 2 weeks

    3. 3

      Build form

      Routed to Market Access.

      Digital and web team 1 week

    4. 4

      Promote at meetings

      AMCP and Asembia.

      National Account Director per meeting

    5. 5

      Track

      Requests by account.

      National Account Director monthly

    6. 6

      Update

      After approval decisions.

      National Account Director as needed

    First result
    2 quarters
    Cost
    Staff time only
    Owner
    National Account Director

    Smallest test

    Add a payer inquiry type to the contact form.

    Why it works

    Add a short page for payers and formulary decision-makers: a request form routed to Market Access, the disease-burden publications (such as the patient-perspective paper in Epilepsia Open) and the infographic, with all content set by Legal and Regulatory within the rules for sharing information with payers before approval.

    It gives payer teams a direct, compliant route and lets Market Access see who is asking.

    Risks and how to handle them

    • Compliance risk

      Legal and Regulatory own the content.

    Evidence

    • HiringNational Account Director (posted September 29, 2026): U.S. market access "with national and large regional commercial payers in preparation for our first launch"; ensure "the value proposition and HEOR data is appropriately communicated to target audiences"; represent Xenon at "AMCP, Asembia".Source
    • Your websiteHealthcare providers page: a "Meet With Your MSL" form (name, NPI number, title, institution, city, state or province); four featured publications (Epilepsia Open, JAMA Network Open, JAMA Neurology); "View All Publications" leaves for investor.xenon-pharma.com/publications; the screen-reader titles of two papers contain raw markup such as "K<sub>V</sub>7".Source
    • Your websiteContact page: inquiry types are Business Development, Careers, Investors, Media and Medical Affairs; there is no Medical Information option or page, and the medical information email appears only on the clinical trials and healthcare providers pages. The Media page offers a media kit with logo, headshots and the epilepsy unmet-need infographic.Source
  • 10

    Xenon has 25 open roles, from CMC and quality to MSLs and payer directors, as it becomes a commercial company. The Join Us page shows "Loading open positions..." in its server HTML, so job search engines and link previews see no roles.

    High impactLow effort First result in 1 month Talent Acquisition

    First action

    Check how many roles appear in Google's job search today.

    How to measure it

    Organic applicants

    Now
    –
    Target
    +30%
    By
    1 quarter

    Steps

    1. 1

      Render roles

      Server-side from Ashby.

      Digital and web team 1 week

    2. 2

      Add markup

      JobPosting per role.

      Digital and web team 3 days

    3. 3

      Team pages

      Commercial, Medical, CMC.

      Talent Acquisition 2 weeks

    4. 4

      Test

      Rich results test.

      Digital and web team 1 day

    5. 5

      Track source

      Applicants by channel.

      Talent Acquisition monthly

    6. 6

      Refresh

      As roles change.

      Digital and web team automatic

    First result
    1 month
    Cost
    Web development time
    Owner
    Talent Acquisition

    Smallest test

    Render the list on the page this week.

    Why it works

    Render the open roles in the HTML with title, location and team, add JobPosting structured data for each, and link team pages (Commercial, Medical, CMC) with a short line on what each team is building now.

    Specialized launch hires are scarce; making each role findable in job search widens the candidate pool at no media cost.

    Risks and how to handle them

    • Duplicate listings

      Point markup to the Ashby apply page.

    Evidence

    • Your websiteHomepage and Media page (checked twice on October 23, 2026): the "Recent news" section is filled in by the browser; the HTML the server sends shows only a loading spinner, so link previews, many crawlers and AI assistants see no news on xenon-pharma.com. The Join Us page's open positions likewise say "Loading open positions...". Press releases live on investor.xenon-pharma.com.Source
    • HiringCompany description in every job post: "In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we submitted a New Drug Application to the Food and Drug Administration in the third quarter of 2026"; X-TOLE3 "would support regulatory submissions outside the U.S."; X-ACKT is in primary generalized tonic-clonic seizures. The Ashby board lists 25 open roles across Boston, Vancouver and U.S. field territories, including CMC and quality roles for "Late Stage/Commercial" manufacturing.Source
    • HiringDirector/Senior Director, Corporate Communications (Needham, MA, posted September 8, 2026): "Increase awareness and visibility of Xenon's emerging leadership in epilepsy, including forthcoming potential launch of azetukalner in focal seizures and our emergence as a leading biopharma company soon to be a fully integrated commercial organization"; owns "corporate newsflow, including business updates, clinical trial milestones, data readouts and future product launches" for "investors and media, healthcare professionals, and the patient community".Source
  • 11

    Xenon published "What Does it Mean to Live With Epilepsy? Burden of Illness From the Patient Perspective" in Epilepsia Open and offers an unmet-need infographic in its media kit. Disease burden is a story journalists can use without discussing an investigational drug.

    Medium impactMedium effort First result in 1 quarter Director/Senior Director

    First action

    Pick three findings from the paper for a one-page summary.

    How to measure it

    Earned mentions

    Now
    –
    Target
    10
    By
    2 quarters

    Steps

    1. 1

      Pick findings

      Three to five.

      Director/Senior Director, Corporate Communications 1 week

    2. 2

      Design charts

      Embeddable.

      Digital and web team 2 weeks

    3. 3

      Partner quotes

      From advocacy groups.

      Associate Director, Patient Marketing 2 weeks

    4. 4

      Review

      Medical and Legal.

      Medical, Legal and Regulatory review 1 week

    5. 5

      Pitch

      Health and trade press.

      Director/Senior Director, Corporate Communications 1 month

    6. 6

      Measure

      Mentions and links.

      Director/Senior Director, Corporate Communications quarterly

    First result
    1 quarter
    Cost
    PR agency time
    Owner
    Director/Senior Director, Corporate Communications

    Smallest test

    Send the one-page summary to five health reporters.

    Why it works

    Turn the paper and infographic into a short, unbranded data story for media and partners: key findings, quotes from advocacy partners, and charts journalists can embed, timed to awareness moments and medical meetings.

    It earns coverage for Xenon's leadership in epilepsy on safe ground and gives partners something to share.

    Risks and how to handle them

    • Seen as promotional

      Keep it unbranded and partner-led.

    Evidence

    • Your websiteHealthcare providers page: a "Meet With Your MSL" form (name, NPI number, title, institution, city, state or province); four featured publications (Epilepsia Open, JAMA Network Open, JAMA Neurology); "View All Publications" leaves for investor.xenon-pharma.com/publications; the screen-reader titles of two papers contain raw markup such as "K<sub>V</sub>7".Source
    • Your websiteContact page: inquiry types are Business Development, Careers, Investors, Media and Medical Affairs; there is no Medical Information option or page, and the medical information email appears only on the clinical trials and healthcare providers pages. The Media page offers a media kit with logo, headshots and the epilepsy unmet-need infographic.Source
    • HiringDirector/Senior Director, Corporate Communications (Needham, MA, posted September 8, 2026): "Increase awareness and visibility of Xenon's emerging leadership in epilepsy, including forthcoming potential launch of azetukalner in focal seizures and our emergence as a leading biopharma company soon to be a fully integrated commercial organization"; owns "corporate newsflow, including business updates, clinical trial milestones, data readouts and future product launches" for "investors and media, healthcare professionals, and the patient community".Source
    • Your websitePatients page: nine community partners (including Epilepsy Foundation of America, Child Neurology Foundation, Cure Epilepsy, Danny Did Foundation and International Bureau for Epilepsy), links to partner resources, an "Ask the Epileptologist" video series, employee stories, and the heading "Driven by scientific breakthoughs".Source
  • 12

    Xenon lists nine epilepsy community partners and links to their resources, and the Patient Marketing hire will run "advocacy partnerships" and measure campaign effectiveness. The links today are a list with no shared goals.

    High impactMedium effort First result in 2 quarters Associate Director

    First action

    Ask each partner which resource they most need.

    How to measure it

    Joint resources published

    Now
    –
    Target
    4
    By
    2 quarters

    Steps

    1. 1

      Ask partners

      Needs and gaps.

      Associate Director, Patient Marketing 1 month

    2. 2

      Agree projects

      Partner-led.

      Associate Director, Patient Marketing 1 month

    3. 3

      Review

      Compliance for support terms.

      Medical, Legal and Regulatory review 2 weeks

    4. 4

      Produce

      With partner teams.

      Associate Director, Patient Marketing 1 quarter

    5. 5

      Share

      Both sites and channels.

      Associate Director, Patient Marketing ongoing

    6. 6

      Measure

      Downloads and feedback.

      Associate Director, Patient Marketing quarterly

    First result
    2 quarters
    Cost
    Grants or sponsorship budget
    Owner
    Associate Director, Patient Marketing

    Smallest test

    Fund one partner-led resource.

    Why it works

    Agree one joint, unbranded resource per partner per year (for example a seizure diary, a caregiver guide or a school toolkit) that the partner leads and Xenon supports, and track downloads and partner feedback.

    Partner-led resources reach patients and families with the trust of the advocacy group and keep Xenon's role supportive rather than promotional.

    Risks and how to handle them

    • Independence concerns

      Partners keep editorial control.

    Evidence

    • Your websitePatients page: nine community partners (including Epilepsy Foundation of America, Child Neurology Foundation, Cure Epilepsy, Danny Did Foundation and International Bureau for Epilepsy), links to partner resources, an "Ask the Epileptologist" video series, employee stories, and the heading "Driven by scientific breakthoughs".Source
    • HiringAssociate Director, Patient Marketing (posted October 15, 2026): works with "Medical Affairs, Advocacy, Market Access, Commercial Operations, Legal, Regulatory"; leads "branded and unbranded marketing initiatives" and "content strategy and execution for patient websites, CRM programs, email campaigns"; partners with analytics "to measure patient attitudes, behaviors, and campaign effectiveness"; supports "advocacy partnerships".Source
  • 13

    Investigator inquiries for X-TOLE3 and X-ACKT go to study email addresses at the bottom of the clinical trials page, and MSLs support investigator identification in epilepsy.

    Medium impactLow effort First result in 1 quarter Senior Medical Science Liaison

    First action

    Ask Clinical Operations which regions still need sites.

    How to measure it

    Qualified site inquiries

    Now
    –
    Target
    +20%
    By
    2 quarters

    Steps

    1. 1

      Confirm needs

      Regions and study.

      Senior Medical Science Liaison 1 week

    2. 2

      Write the page

      Registry wording only.

      Senior Medical Science Liaison 1 week

    3. 3

      Review

      Regulatory and Legal.

      Medical, Legal and Regulatory review 1 week

    4. 4

      Build form

      Routed to Clinical Operations.

      Digital and web team 1 week

    5. 5

      Share

      MSLs and congresses.

      Senior Medical Science Liaison ongoing

    6. 6

      Track

      Inquiries to activated sites.

      Senior Medical Science Liaison monthly

    First result
    1 quarter
    Cost
    Staff time only
    Owner
    Senior Medical Science Liaison

    Smallest test

    Replace the two emails with one routed form.

    Why it works

    Build a short page for prospective investigators and site staff: study summaries in registry wording, regions where sites are sought, what the sponsor provides, a request form routed to Clinical Operations, and a link for MSLs to share.

    A clear site-facing page helps MSLs and Clinical Operations find qualified investigators faster.

    Risks and how to handle them

    • Studies close to new sites

      Remove the page when site needs end.

    Evidence

    • Your websiteClinical trials page: study designs for focal seizures (X-TOLE2, X-TOLE3), generalized seizures (X-ACKT), major depressive disorder (X-NOVA2, X-NOVA3) and bipolar depression (X-CEED), each followed by "To learn more about enrollment in the study, visit:" and ClinicalTrials.gov links; investigator inquiries go to study email addresses; general questions to [email protected]; the page contains the typo "placeo".Source
    • HiringSenior Medical Science Liaison, Southeast (posted September 10, 2026): engages HCPs, KOLs and patient groups "to provide education on Xenon's pipeline in epilepsy"; responds to "unsolicited requests for scientific information"; supports "investigator identification for clinical programs in epilepsy"; leads congress activities.Source
    • HiringCompany description in every job post: "In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we submitted a New Drug Application to the Food and Drug Administration in the third quarter of 2026"; X-TOLE3 "would support regulatory submissions outside the U.S."; X-ACKT is in primary generalized tonic-clonic seizures. The Ashby board lists 25 open roles across Boston, Vancouver and U.S. field territories, including CMC and quality roles for "Late Stage/Commercial" manufacturing.Source
  • 14

    Strategic Engagement directors and MSLs lead congress activities, and Xenon presents data at epilepsy and neurology meetings. After each meeting, the presentations are hard to find on the corporate site.

    Medium impactLow effort First result in 1 quarter Director

    First action

    Collect the last year's congress presentations.

    How to measure it

    Post-congress visits

    Now
    –
    Target
    +40%
    By
    2 quarters

    Steps

    1. 1

      Collect

      Past year.

      Senior Medical Science Liaison 2 weeks

    2. 2

      Approve

      What can be posted.

      Medical, Legal and Regulatory review 2 weeks

    3. 3

      Build page

      By meeting.

      Digital and web team 1 week

    4. 4

      Update

      Within a week of each congress.

      Director, Strategic Engagements per congress

    5. 5

      Link

      MSL follow-ups and releases.

      Director/Senior Director, Corporate Communications ongoing

    6. 6

      Measure

      Visits and MSL requests.

      Digital and web team quarterly

    First result
    1 quarter
    Cost
    Staff time only
    Owner
    Director, Strategic Engagements

    Smallest test

    Post the last meeting's presentations.

    Why it works

    Keep one page listing each congress, the presentations given and, where approved, the poster PDFs; MSLs link to it in follow-ups and the communications team links it in releases.

    It extends the life of each congress presentation and gives HCPs who missed it one place to look.

    Risks and how to handle them

    • Posting embargoes

      Post after each meeting's embargo ends.

    Evidence

    • HiringDirector, Strategic Engagements, Northeast and Central (both posted October 21, 2026): "KOL Engagement", "commercial KOL influence mapping", "field-based educational events (many occurring on weekends)", advisory boards and congresses, "in a compliant manner", reporting to the Senior Director, Customer Engagement.Source
    • HiringSenior Medical Science Liaison, Southeast (posted September 10, 2026): engages HCPs, KOLs and patient groups "to provide education on Xenon's pipeline in epilepsy"; responds to "unsolicited requests for scientific information"; supports "investigator identification for clinical programs in epilepsy"; leads congress activities.Source
    • Your websiteHealthcare providers page: a "Meet With Your MSL" form (name, NPI number, title, institution, city, state or province); four featured publications (Epilepsia Open, JAMA Network Open, JAMA Neurology); "View All Publications" leaves for investor.xenon-pharma.com/publications; the screen-reader titles of two papers contain raw markup such as "K<sub>V</sub>7".Source
  • 15

    The Patient Marketing hire must measure campaign effectiveness and the Corporate Communications hire is measured on awareness. Xenon's audiences move between xenon-pharma.com, investor.xenon-pharma.com and Ashby, and the corporate site runs Google Tag Manager without a shared set of goals.

    Medium impactMedium effort First result in 1 quarter Associate Director

    First action

    List the five goals per audience.

    How to measure it

    Tracked goals

    Now
    –
    Target
    All agreed goals
    By
    1 quarter

    Steps

    1. 1

      Agree goals

      Per audience.

      Associate Director, Patient Marketing 2 weeks

    2. 2

      Consent check

      Privacy and cookie rules.

      Medical, Legal and Regulatory review 1 week

    3. 3

      Set up tracking

      Three sites.

      Digital and web team 2 weeks

    4. 4

      Build report

      Monthly.

      Associate Director, Patient Marketing 1 week

    5. 5

      Review

      With Corporate Affairs.

      Director/Senior Director, Corporate Communications monthly

    6. 6

      Act

      Shift effort to what works.

      Director/Senior Director, Corporate Communications quarterly

    First result
    1 quarter
    Cost
    Analytics time
    Owner
    Associate Director, Patient Marketing

    Smallest test

    Track MSL form submissions by source this month.

    Why it works

    Define one set of goals per audience (MSL requests, MI requests, media kit downloads, publication clicks, job applications), track them across the three sites with consent, and report monthly to Corporate Affairs and Medical Affairs.

    Shared numbers show which content serves HCPs, media and candidates, and where to invest.

    Risks and how to handle them

    • Health data sensitivity

      Track page goals only; no health data.

    Evidence

    • HiringAssociate Director, Patient Marketing (posted October 15, 2026): works with "Medical Affairs, Advocacy, Market Access, Commercial Operations, Legal, Regulatory"; leads "branded and unbranded marketing initiatives" and "content strategy and execution for patient websites, CRM programs, email campaigns"; partners with analytics "to measure patient attitudes, behaviors, and campaign effectiveness"; supports "advocacy partnerships".Source
    • HiringDirector/Senior Director, Corporate Communications (Needham, MA, posted September 8, 2026): "Increase awareness and visibility of Xenon's emerging leadership in epilepsy, including forthcoming potential launch of azetukalner in focal seizures and our emergence as a leading biopharma company soon to be a fully integrated commercial organization"; owns "corporate newsflow, including business updates, clinical trial milestones, data readouts and future product launches" for "investors and media, healthcare professionals, and the patient community".Source
    • Your websiteHomepage and Media page (checked twice on October 23, 2026): the "Recent news" section is filled in by the browser; the HTML the server sends shows only a loading spinner, so link previews, many crawlers and AI assistants see no news on xenon-pharma.com. The Join Us page's open positions likewise say "Loading open positions...". Press releases live on investor.xenon-pharma.com.Source
    • Your websiteHealthcare providers page: a "Meet With Your MSL" form (name, NPI number, title, institution, city, state or province); four featured publications (Epilepsia Open, JAMA Network Open, JAMA Neurology); "View All Publications" leaves for investor.xenon-pharma.com/publications; the screen-reader titles of two papers contain raw markup such as "K<sub>V</sub>7".Source

Big bets 3

Larger plays that can change the trajectory.

  • 16

    The Director of Medical Information is asked to build "omnichannel MI delivery and self-service portals" and a contact center ahead of commercialization.

    High impactHigh effort First result in 3 quarters Director

    First action

    Map today's request routes and volumes.

    How to measure it

    Self-served requests

    Now
    –
    Target
    30%
    By
    3 quarters

    Steps

    1. 1

      Map routes

      Email, form, MSL.

      Director, Medical Information 1 month

    2. 2

      Pick platform

      With the contact center vendor.

      Director, Medical Information 1 month

    3. 3

      Load content

      Approved responses.

      Director, Medical Information 1 quarter

    4. 4

      Review

      Compliance and safety.

      Medical, Legal and Regulatory review 1 month

    5. 5

      Launch

      Provider pages.

      Digital and web team 1 month

    6. 6

      Measure

      Volume, topics, time to answer.

      Director, Medical Information monthly

    First result
    3 quarters
    Cost
    Platform and vendor costs
    Owner
    Director, Medical Information

    Smallest test

    Pilot request logging on the new Medical Information page.

    Why it works

    Build one portal where HCPs can search approved scientific responses, request a standard response letter, ask a question, or request an MSL, with each request logged in the MI system and routed to the contact center or regional MSL.

    HCPs get answers when they need them, and Xenon gets a compliant, measurable record of scientific demand by topic and region.

    Risks and how to handle them

    • Safety reports arrive through the portal

      Route possible adverse events to drug safety by design.

    Evidence

    • HiringDirector, Medical Information (posted August 13, 2026): build the Medical Information function, including "contact center operations, digital capabilities, and scientific content management", "Standard Response Letters (SRLs)", "omnichannel MI delivery and self-service portals" and "a Medical Information portal".Source
    • HiringSenior Medical Science Liaison, Southeast (posted September 10, 2026): engages HCPs, KOLs and patient groups "to provide education on Xenon's pipeline in epilepsy"; responds to "unsolicited requests for scientific information"; supports "investigator identification for clinical programs in epilepsy"; leads congress activities.Source
    • Your websiteHealthcare providers page: a "Meet With Your MSL" form (name, NPI number, title, institution, city, state or province); four featured publications (Epilepsia Open, JAMA Network Open, JAMA Neurology); "View All Publications" leaves for investor.xenon-pharma.com/publications; the screen-reader titles of two papers contain raw markup such as "K<sub>V</sub>7".Source
    • Your websiteContact page: inquiry types are Business Development, Careers, Investors, Media and Medical Affairs; there is no Medical Information option or page, and the medical information email appears only on the clinical trials and healthcare providers pages. The Media page offers a media kit with logo, headshots and the epilepsy unmet-need infographic.Source
  • 17

    Xenon's own Epilepsia Open paper studied the burden of epilepsy from patients' perspective, and its therapeutic areas page says about half of people with focal epilepsy still have uncontrolled seizures. Payers, HCPs and media all value such evidence.

    High impactHigh effort First result in 4 quarters Associate Director

    First action

    Propose the survey to two partners.

    How to measure it

    Partner organizations sharing results

    Now
    –
    Target
    5
    By
    4 quarters

    Steps

    1. 1

      Design with partners

      Questions and governance.

      Associate Director, Patient Marketing 1 quarter

    2. 2

      Ethics review

      Survey approval.

      Medical, Legal and Regulatory review 1 month

    3. 3

      Field

      Through partners.

      Associate Director, Patient Marketing 1 quarter

    4. 4

      Analyze

      With HEOR.

      National Account Director 1 month

    5. 5

      Publish

      Journal and summary.

      Director/Senior Director, Corporate Communications 1 quarter

    6. 6

      Repeat

      Yearly.

      Associate Director, Patient Marketing yearly

    First result
    4 quarters
    Cost
    Research budget
    Owner
    Associate Director, Patient Marketing

    Smallest test

    Agree a three-question pilot with one partner.

    Why it works

    Run a yearly survey with advocacy partners on living with uncontrolled seizures (daily impact, caregiver load, work and school), publish it in a journal and as an open summary, and share findings with partners first.

    Repeated, partner-run research makes Xenon a source on the lived experience of epilepsy and supports market access and medical education with data.

    Risks and how to handle them

    • Seen as marketing

      Independent governance and open methods.

    Evidence

    • Your websiteHealthcare providers page: a "Meet With Your MSL" form (name, NPI number, title, institution, city, state or province); four featured publications (Epilepsia Open, JAMA Network Open, JAMA Neurology); "View All Publications" leaves for investor.xenon-pharma.com/publications; the screen-reader titles of two papers contain raw markup such as "K<sub>V</sub>7".Source
    • Your websiteTherapeutic areas page: epilepsy "affects nearly 3 million adults in the U.S."; "more than 30 ASMs are available today. However, despite treatment, about half of people with focal epilepsy still live with uncontrolled seizures"; an unmet-need infographic and more "Ask the Epileptologist" conversations.Source
    • Your websitePatients page: nine community partners (including Epilepsy Foundation of America, Child Neurology Foundation, Cure Epilepsy, Danny Did Foundation and International Bureau for Epilepsy), links to partner resources, an "Ask the Epileptologist" video series, employee stories, and the heading "Driven by scientific breakthoughs".Source
    • HiringNational Account Director (posted September 29, 2026): U.S. market access "with national and large regional commercial payers in preparation for our first launch"; ensure "the value proposition and HEOR data is appropriately communicated to target audiences"; represent Xenon at "AMCP, Asembia".Source
  • 18

    Four new functions (Corporate Communications, Medical Information, Strategic Engagements and Market Access) will each produce materials for HCPs, payers and media, all needing medical, legal and regulatory review.

    High impactMedium effort First result in 3 quarters Director/Senior Director

    First action

    Inventory the assets each team has today.

    How to measure it

    Reuse rate

    Now
    –
    Target
    50% of new requests
    By
    3 quarters

    Steps

    1. 1

      Inventory

      All teams.

      Director/Senior Director, Corporate Communications 1 month

    2. 2

      Tag

      Audience, status, expiry.

      Medical, Legal and Regulatory review 1 month

    3. 3

      Pick tool

      Existing review system if possible.

      Director/Senior Director, Corporate Communications 1 month

    4. 4

      Migrate

      Approved assets.

      Director/Senior Director, Corporate Communications 1 quarter

    5. 5

      Train

      All four teams.

      Director/Senior Director, Corporate Communications 1 month

    6. 6

      Measure

      Reuse and review time.

      Medical, Legal and Regulatory review quarterly

    First result
    3 quarters
    Cost
    Tooling and setup time
    Owner
    Director/Senior Director, Corporate Communications

    Smallest test

    Share one library folder across two teams for a month.

    Why it works

    Set up one content library with approval status, audience and expiry for every asset (publication summaries, infographics, response letters, media kit items), so each team reuses approved pieces instead of commissioning new ones.

    Shared, approved content speeds review, keeps messages consistent across audiences and cuts agency spend.

    Risks and how to handle them

    • Expired content in use

      Automatic expiry and alerts.

    Evidence

    • HiringDirector/Senior Director, Corporate Communications (Needham, MA, posted September 8, 2026): "Increase awareness and visibility of Xenon's emerging leadership in epilepsy, including forthcoming potential launch of azetukalner in focal seizures and our emergence as a leading biopharma company soon to be a fully integrated commercial organization"; owns "corporate newsflow, including business updates, clinical trial milestones, data readouts and future product launches" for "investors and media, healthcare professionals, and the patient community".Source
    • HiringDirector, Medical Information (posted August 13, 2026): build the Medical Information function, including "contact center operations, digital capabilities, and scientific content management", "Standard Response Letters (SRLs)", "omnichannel MI delivery and self-service portals" and "a Medical Information portal".Source
    • HiringDirector, Strategic Engagements, Northeast and Central (both posted October 21, 2026): "KOL Engagement", "commercial KOL influence mapping", "field-based educational events (many occurring on weekends)", advisory boards and congresses, "in a compliant manner", reporting to the Senior Director, Customer Engagement.Source
    • HiringNational Account Director (posted September 29, 2026): U.S. market access "with national and large regional commercial payers in preparation for our first launch"; ensure "the value proposition and HEOR data is appropriately communicated to target audiences"; represent Xenon at "AMCP, Asembia".Source

Wildcards 2

Unexpected experiments, each with a cheap way to test it.

  • 19

    Xenon's Science and Therapeutic areas pages explain ion channels in text, and another company (Biohaven) also describes a Kv7 program in focal epilepsy. A clear, visual explainer of the mechanism, without product claims, helps investors, students and candidates understand the science.

    Medium impactLow effort First result in 1 quarter Director/Senior Director

    First action

    Storyboard the explainer from the Science page text.

    How to measure it

    Explainer views

    Now
    –
    Target
    10,000
    By
    2 quarters

    Steps

    1. 1

      Storyboard

      From approved text.

      Director/Senior Director, Corporate Communications 2 weeks

    2. 2

      Review

      Medical and Legal.

      Medical, Legal and Regulatory review 2 weeks

    3. 3

      Animate

      Agency.

      Director/Senior Director, Corporate Communications 1 month

    4. 4

      Publish

      Science page.

      Digital and web team 1 week

    5. 5

      Use widely

      Investors and careers.

      Director/Senior Director, Corporate Communications ongoing

    6. 6

      Measure

      Views and shares.

      Director/Senior Director, Corporate Communications quarterly

    First result
    1 quarter
    Cost
    Animation budget
    Owner
    Director/Senior Director, Corporate Communications

    Smallest test

    Make a 30-second version for LinkedIn.

    Why it works

    Build a short animated explainer of a neuron firing, how sodium and potassium channels open and close, and what goes wrong in a seizure, using the wording already on the Science page. Use it on the site, at careers fairs and in investor materials.

    A memorable explanation of the science supports Xenon's leadership in ion channel research with every audience.

    Risks and how to handle them

    • Implied product claims

      Describe the biology only.

    Evidence

    • Your websiteTherapeutic areas page: epilepsy "affects nearly 3 million adults in the U.S."; "more than 30 ASMs are available today. However, despite treatment, about half of people with focal epilepsy still live with uncontrolled seizures"; an unmet-need infographic and more "Ask the Epileptologist" conversations.Source
    • Competitor researchBiohaven lists opakalim (BHV-7000), a "Kv7 Activator" for "Focal Epilepsy", on its pipeline page, describing it as "a potent, selective activator of Kv7.2/7.3 potassium channels".Source
    • HiringDirector/Senior Director, Corporate Communications (Needham, MA, posted September 8, 2026): "Increase awareness and visibility of Xenon's emerging leadership in epilepsy, including forthcoming potential launch of azetukalner in focal seizures and our emergence as a leading biopharma company soon to be a fully integrated commercial organization"; owns "corporate newsflow, including business updates, clinical trial milestones, data readouts and future product launches" for "investors and media, healthcare professionals, and the patient community".Source
  • 20

    The Patients page already features an MSL who volunteers with Care Epilepsy Ethiopia, and Xenon is hiring MSLs, strategic engagement directors and payer directors across the U.S.

    Medium impactLow effort First result in 1 quarter Talent Acquisition

    First action

    Interview three field employees.

    How to measure it

    Applicants per field role

    Now
    –
    Target
    +20%
    By
    2 quarters

    Steps

    1. 1

      Pick people

      Field and medical.

      Talent Acquisition 1 week

    2. 2

      Interview

      Short stories.

      Director/Senior Director, Corporate Communications 2 weeks

    3. 3

      Review

      Legal.

      Medical, Legal and Regulatory review 1 week

    4. 4

      Publish

      Join Us and LinkedIn.

      Talent Acquisition 1 week

    5. 5

      Link

      From job posts.

      Talent Acquisition ongoing

    6. 6

      Measure

      Applicants by source.

      Talent Acquisition monthly

    First result
    1 quarter
    Cost
    Video time
    Owner
    Talent Acquisition

    Smallest test

    Post one story on LinkedIn.

    Why it works

    Publish short stories and videos from field and medical employees on why they joined, what their work involves and how they stay connected to the epilepsy community; share them on LinkedIn and on the relevant job posts.

    Experienced field talent chooses employers by mission and people, and peers tell that story better than job ads.

    Risks and how to handle them

    • Staff turnover

      Refresh stories yearly.

    Evidence

    • Your websitePatients page employee stories: a Senior Medical Science Liaison describes volunteering with Care Epilepsy Ethiopia and giving "virtual lectures on antiseizure medicines to practitioners on the ground".Source
    • HiringCompany description in every job post: "In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we submitted a New Drug Application to the Food and Drug Administration in the third quarter of 2026"; X-TOLE3 "would support regulatory submissions outside the U.S."; X-ACKT is in primary generalized tonic-clonic seizures. The Ashby board lists 25 open roles across Boston, Vancouver and U.S. field territories, including CMC and quality roles for "Late Stage/Commercial" manufacturing.Source
    • HiringDirector, Strategic Engagements, Northeast and Central (both posted October 21, 2026): "KOL Engagement", "commercial KOL influence mapping", "field-based educational events (many occurring on weekends)", advisory boards and congresses, "in a compliant manner", reporting to the Senior Director, Customer Engagement.Source

03

How Programmable can help

Where an idea in this playbook is something Programmable builds or runs, it's listed here with what we'd do. Everything else is yours to run.

ProgrammableDigital

Show it, don't just describe it

These ideas need something to show: a demo, a video, an animation, graphics or a deck. Digital turns screenshots or the site into all of them, in the company's own brand.

Make a demo (opens programmable.digital in a new tab)
More example playbooks and reviews

More growth playbooks

Other companies we have researched, each read from what they are hiring for.

  • Kepler growth strategyA verifiable AI platform for high-stakes research, starting with finance: the model plans the work while deterministic code retrieves and…21 growth ideas
  • automatics growth strategyAn independent product engineering studio in Düsseldorf, run by a four-time startup CTO. It works as a fractional CTO and builds AI…22 growth ideas
  • Alchemy growth strategyA blockchain developer platform: node RPC APIs across 100+ chains, data APIs, webhooks, wallet and transaction APIs, rollups, validators…22 growth ideas
  • Ahrefs growth strategyAn AI marketing platform built on its own web index: Site Explorer, Keywords Explorer, Brand Radar for AI visibility, Site Audit, Rank…21 growth ideas
  • Kraken growth strategyA crypto exchange and trading platform (part of Payward) offering spot, margin, futures, staking, tokenized stocks (xStocks), the Krak…21 growth ideas
  • Sourcebot growth strategyA self-hosted code understanding tool: regex and symbol-aware code search, code navigation, Ask Sourcebot (plain-English questions…22 growth ideas
  • Life360 growth strategyA family safety app and membership: location sharing, driving reports, crash detection with emergency dispatch, SOS, identity protection…22 growth ideas
  • Lightberry growth strategyA San Francisco robotics company building the software, sensors and character for social robots. Its product is Lumi, a 1.3 m interactive…21 growth ideas

See every playbook and website review

Independent research. Programmable wrote this playbook from public sources, as they stood on October 26, 2026, and cites them throughout. Xenon Pharmaceuticals did not commission, review or endorse it, and Programmable is not affiliated with Xenon Pharmaceuticals. Company and product names are trademarks of their owners, used only to identify them. The ideas are suggestions and opinion, not professional, legal or financial advice, and not statements about how Xenon Pharmaceuticals runs its business.

Something wrong, or do you represent Xenon Pharmaceuticals? Email [email protected] and we will correct it or take it down.

30/60/90 roadmap

What to focus on in each month, and the ideas that carry it.

  1. Days 1 to 306 ideas

    Newsflow on the site, trial status labels, proofreading, the publications library, a lighter homepage and a Medical Information page.

  2. Days 31 to 6011 ideas

    MSL routing, the specialist series, payer route, job search markup, the data story, partner resources, investigator page, congress page and shared measurement; the science explainer and employee stories.

  3. Days 61 to 903 ideas

    Commit to the MI portal, the yearly patient-perspective research and the shared content system.

The research behind the plan

3 research areas, each summarised in a few lines. Open any of them for the full detail.

Customers

What customers say

Customers value science-led communication from ion channel specialists. The most cited problem: about half of people with focal epilepsy still have uncontrolled seizures, per Xenon.

  • Visible partnership with epilepsy advocacy groups
  • Polytherapy and drug interactions
  • In their words: “uncontrolled seizures”

Market

Competitive landscape

3 competitors compared: Biohaven (opakalim, BHV-7000), Established antiseizure medicines and Other neuroscience companies building epilepsy franchises.

  • Gap to exploit: A single trusted source of scientific information for HCPs before approval
  • Biohaven (opakalim, BHV-7000): Earlier regulatory stage than an NDA
  • Established antiseizure medicines: Many rely on long-known mechanisms, per Xenon

Hiring signals

Xenon is building the outward-facing functions of a commercial company.

  • Director/Senior Director, Corporate Communications: Awareness of leadership in epilepsy; corporate newsflow. Ideas 1, 11, 18.
  • Associate Director, Patient Marketing: Advocacy partnerships, websites and measurement. Ideas 12, 15, 17.
  • Director, Medical Information: Contact center, response letters, self-service portal. Ideas 6, 16.

From the team that wrote this playbook

All products
  • ProgrammableAgencyWorking AI systems in days, not quarters (opens programmable.agency in a new tab)
  • ProgrammableInfoAn agent that finds, researches and asks firstNew accounts get 100,000 free enrichment credits with code BETA100K (opens programmable.info in a new tab)
  • ProgrammableDigitalScreenshots in, an animated product demo out (opens programmable.digital in a new tab)
  • ProgrammableWatchKnow the day a supplier falls out of compliance (opens programmable.watch in a new tab)
  • ProgrammableTalkGet registrants for your events, and know who’s coming (opens programmable.talk in a new tab)
  • ProgrammableMediaAn AI note taker, interpreter and webinar host for your calls (opens programmable.media in a new tab)
  • ProgrammablePageText what you need, your customer gets a page that works (opens programmable.page in a new tab)
  • ProgrammableCommunityForums with labelled AI members, never empty (opens programmable.community in a new tab)
ProgrammableMarketing
ExamplesLeaderboardsProductsTermsPrivacyCookiesDPALegalContact

© 2026 AI-Powered Growth Intelligence